SCHEMBL3333857

SCHEMBL3333857

Fc1cccc(-c2nc3cc(Cl)ccc3[nH]2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 3/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
TP53 P04637 2/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
CYP3A4 P08684 1/20 0.54
MAPT P10636 1/20 0.54
MAPK1 P28482 1/20 0.54
FTO Q9C0B1 1/20 0.54
MGAM O43451 2/20 0.52
GAA P10253 2/20 0.52
SI P14410 2/20 0.52
MGAM2 Q2M2H8 2/20 0.52
THRB P10828 1/20 0.50
GUSB P08236 1/20 0.48
SCD O00767 1/20 0.46
NPBWR1 P48145 1/20 0.46
NPC1 O15118 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3336441 0.88 KDM4E (0.59) ALDH1A1KDM4EMEN1KMT2ATP53
SCHEMBL22956059 0.84 KDM4E (0.63) ALDH1A1KDM4EMEN1KMT2ATP53
SCHEMBL3333026 0.83 KDM4E (0.61) ALDH1A1KDM4EMEN1KMT2ATP53
SCHEMBL3335842 0.83 KDM4E (0.76) ALDH1A1KDM4EMEN1KMT2ATP53
SCHEMBL7396441 0.82 KDM4E (0.54) ALDH1A1KDM4EMEN1KMT2ATP53
SCHEMBL26753825 0.82 MGAM (0.52) ALDH1A1KDM4ETP53HPGDHSD17B10
SCHEMBL31289464 0.82 MEN1 (0.61) ALDH1A1KDM4EMEN1KMT2ATP53
SCHEMBL22955338 0.82 CYP3A4 (0.55) ALDH1A1KDM4EMEN1KMT2ATP53
SCHEMBL4122566 0.81 NPC1 (0.68) ALDH1A1KDM4EMEN1KMT2ATP53
SCHEMBL9032997 0.81 ALDH1A1 (0.62) ALDH1A1KDM4EMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198307-B2 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2012-06-12 US disclosed
US-20100145054-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145054-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME TYR, MCHR1, MCHR2 ALDH1A1 448/4885KDM4E 220/4885MEN1 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.